Schedule 13D ownership disclosure
Climb Bio, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 28658R106
Event date: 2025-10-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AI ETI LLCReported CIK 0001871741
Shares: 0 · Class: 0.0%
- Access Industries Holdings LLCReported CIK 0001391297
Shares: 0 · Class: 0.0%
- Access Industries Management, LLCReported CIK 0001508226
Shares: 0 · Class: 0.0%
- Len BlavatnikReported CIK 0001326628
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-241629
- Form type
- SCHEDULE 13D/A
- Filer
- AI ETI LLC
- CIK
- CIK 1871741
- Filed
- Oct 16, 2025
- Reporting period
- Oct 14, 2025
- Description
- Schedule 13D beneficial ownership